Overview
Torasemide is a high-ceiling loop diuretic. Structurally, it is a pyridine-sulfonylurea used as an antihypertensive agent. Torasemide was first approved for clinical use by the FDA in 1993.
Indication
Torasemide is indicated for the treatment of edema associated with congestive heart failure, renal or hepatic diseases. From this condition, it has been observed that torasemide is very effective in cases of kidney failure. As well, torasemide is approved to be used as an antihypertensive agent either alone or in combination with other antihypertensives.
Associated Conditions
- Edema
- Hypertension
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/11/27 | Phase 4 | Terminated | |||
2024/11/01 | Phase 2 | Recruiting | Jemincare | ||
2024/05/14 | Phase 3 | Completed | Ospedale San Raffaele | ||
2024/03/04 | Phase 1 | Completed | |||
2024/02/23 | Phase 4 | Recruiting | National Institute of Cardiology, Warsaw, Poland | ||
2024/01/23 | Phase 4 | Recruiting | |||
2024/01/16 | Phase 2 | Recruiting | |||
2023/09/15 | N/A | Recruiting | China National Center for Cardiovascular Diseases | ||
2023/09/15 | N/A | Recruiting | China National Center for Cardiovascular Diseases | ||
2023/09/14 | N/A | Recruiting | China National Center for Cardiovascular Diseases |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Sarfez Pharmaceuticals Inc | 73502-286 | ORAL | 20 mg in 1 1 | 12/28/2021 | |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-874 | ORAL | 100 mg in 1 1 | 7/17/2023 | |
| Teva Pharmaceuticals USA, Inc. | 50111-915 | ORAL | 5 mg in 1 1 | 2/28/2017 | |
| Carilion Materials Management | 68151-2946 | ORAL | 5 mg in 1 1 | 10/3/2012 | |
| Camber Pharmaceuticals, Inc. | 31722-530 | ORAL | 10 mg in 1 1 | 8/18/2017 | |
| Bryant Ranch Prepack | 63629-1346 | ORAL | 10 mg in 1 1 | 5/23/2023 | |
| Rising Health, LLC | 57237-141 | ORAL | 100 mg in 1 1 | 6/14/2023 | |
| Aurobindo Pharma Limited | 65862-125 | ORAL | 5 mg in 1 1 | 6/14/2023 | |
| Rising Health, LLC | 57237-138 | ORAL | 5 mg in 1 1 | 6/14/2023 | |
| Sarfez Pharmaceuticals Inc | 73502-288 | ORAL | 60 mg in 1 1 | 12/28/2021 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| DEMADEX TABLETS - 5MG | Hoffmann-La Roche Limited | 02129000 | Tablet - Oral | 5 MG | 12/31/1995 |
| DEMADEX TABLETS - 100MG | Hoffmann-La Roche Limited | 02129035 | Tablet - Oral | 100 MG | 12/31/1995 |
| DEMADEX TABLETS - 20MG | Hoffmann-La Roche Limited | 02129027 | Tablet - Oral | 20 MG | 12/31/1996 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| TORASEMIDA SANDOZ 10 MG COMPRIMIDOS EFG | Sandoz Farmaceutica S.A. | 66332 | COMPRIMIDO | Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración | Commercialized |
| SUTRIL NEO 10 mg COMPRIMIDOS DE LIBERACION PROLONGADA | 67987 | COMPRIMIDO DE LIBERACIÓN PROLONGADA | Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración | Not Commercialized | |
| TORASEMIDA SANDOZ 5 MG COMPRIMIDOS EFG | Sandoz Farmaceutica S.A. | 66331 | COMPRIMIDO | Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración | Commercialized |
| TORASEMIDA NORMON 5 mg COMPRIMIDOS EFG | Laboratorios Normon S.A. | 67313 | COMPRIMIDO | Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración | Commercialized |
| SUTRIL NEO 5 mg COMPRIMIDOS DE LIBERACION PROLONGADA | 67986 | COMPRIMIDO DE LIBERACIÓN PROLONGADA | Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración | Not Commercialized | |
| TORASEMIDA ARISTO 5 mg COMPRIMIDOS EFG | Aristo Pharma Iberia S.L. | 68265 | COMPRIMIDO | Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración | Not Commercialized |
| TORASEMIDA NORMON 10 mg COMPRIMIDOS EFG | Laboratorios Normon S.A. | 67314 | COMPRIMIDO | Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración | Commercialized |
| TORASEMIDA NORMON 2,5 mg COMPRIMIDOS EFG | Laboratorios Normon S.A. | 67312 | COMPRIMIDO | Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración | Commercialized |
| TORASEMIDA CINFA 5 mg COMPRIMIDOS EFG | Laboratorios Cinfa S.A. | 66314 | COMPRIMIDO | Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración | Commercialized |
| TORASEMIDA COMBIX 10 mg COMPRIMIDOS EFG | Laboratorios Combix S.L.U. | 66429 | COMPRIMIDO | Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.